{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:22:04Z","timestamp":1785205324880,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T00:00:00Z","timestamp":1644019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["Grupos Estables Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer"],"award-info":[{"award-number":["Grupos Estables Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s00428-022-03291-x","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T17:02:18Z","timestamp":1644080538000},"page":"1031-1039","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of the Idylla\u2122 MSI assay with the Promega\u2122 MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study"],"prefix":"10.1007","volume":"480","author":[{"given":"Sonia","family":"Gatius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Varela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cuatrecasas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Jares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Setaffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bonhomme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Santon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lindemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Matias-Guiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,5]]},"reference":[{"key":"3291_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/his.12053","volume":"62","author":"X Matias-Guiu","year":"2013","unstructured":"Matias-Guiu X, Prat J (2013) Molecular pathology of endometrial carcinoma. Histopathology 62:111\u2013123","journal-title":"Histopathology"},{"key":"3291_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ygyno.2020.10.012","volume":"160","author":"H Hampel","year":"2021","unstructured":"Hampel H, Pearlman R, de la Chapelle A, Pritchard CC, Zhao W, Jones D et al (2021) Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients. Gynecol Oncol 160:161\u2013168","journal-title":"Gynecol Oncol"},{"key":"3291_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/cncr.21560","volume":"106","author":"RR Broaddus","year":"2006","unstructured":"Broaddus RR, Lynch HT, Chen LM, Daniels MS, Conrad P, Munsell MF et al (2006) Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma. Cancer 106:87\u201394","journal-title":"Cancer"},{"key":"3291_CR4","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1136\/ijgc-00009577-200605000-00067","volume":"16","author":"LH Honore","year":"2006","unstructured":"Honore LH, Hanson J, Andrew SE (2006) Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables. Int J Gynecol Cancer 16:1386\u20131392","journal-title":"Int J Gynecol Cancer"},{"key":"3291_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.humpath.2007.05.022","volume":"39","author":"J Shia","year":"2008","unstructured":"Shia J, Black D, Hummer AJ, Boyd J, Soslow RA (2008) Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Hum Pathol 39:116\u2013125","journal-title":"Hum Pathol"},{"key":"3291_CR6","doi-asserted-by":"crossref","unstructured":"Luis A. Diaz, Jennifer N. Uram, Hao Wang, Bjarne Bartlett, Holly Kemberling, Aleksandra Eyring, Nilofer Saba Azad, Tianna Dauses, Dan Laheru, James J. Lee, Todd S. Crocenzi, Richard M. Goldberg, George A. Fisher, Tim F. Greten, Christian Frederick Meyer, Amanda Nickles Fader, Deborah Kay Armstrong, Minori Koshiji, Bert Vogelstein, Dung T. Le (2016). Programmed death-1 blockade in mismatch repair deficient cancer independent of tumour histology. J Clin Oncol 34:15_suppl, 3003\u20133003.","DOI":"10.1200\/JCO.2016.34.15_suppl.3003"},{"issue":"15_ suppl","key":"3291_CR7","doi-asserted-by":"publisher","first-page":"5581","DOI":"10.1200\/JCO.2016.34.15_suppl.5581","volume":"34","author":"PA Ott","year":"2016","unstructured":"Ott PA, Bang Y-J, Berton-Rigaud D, Elez E, Pishvaian MJ, Rugo HS et al (2016) Pembrolizumab in advanced endometrial cancer: preliminary results from the phase Ib KEYNOTE-028 study. J Clin Oncol 34(15_ suppl):5581","journal-title":"J Clin Oncol"},{"key":"3291_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"The Cancer Genome Atlas Research Network","year":"2013","unstructured":"The Cancer Genome Atlas Research Network (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67\u201373","journal-title":"Nature"},{"key":"3291_CR9","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ygyno.2016.12.015","volume":"145","author":"JM Piulats","year":"2017","unstructured":"Piulats JM, Guerra E, Gil-Mart\u00edn M, Roman-Canal B, Gatius S, Sanz-Pamplona R et al (2017) Molecular approaches for classifying endometrial carcinoma. Gynecol Oncol 145:200\u2013207","journal-title":"Gynecol Oncol"},{"key":"3291_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/bjc.2015.190","volume":"113","author":"A Talhouk","year":"2015","unstructured":"Talhouk A, McConechy MK, Leung S, Li-Chang HH, Kwon JS, Melnyk N et al (2015) A clinically applicable molecular-based classification for endometrial cancers. Br J Cancer 113:299\u2013310","journal-title":"Br J Cancer"},{"key":"3291_CR11","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/his.14015","volume":"76","author":"L Vermij","year":"2020","unstructured":"Vermij L, Smit V, Nout R, Bosse T (2020) Incorporation of molecular characteristics into endometrial cancer management. Histopathology 76:52\u201363","journal-title":"Histopathology"},{"key":"3291_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.5372","volume":"250","author":"A Le\u00f3n-Castillo","year":"2020","unstructured":"Le\u00f3n-Castillo A, Britton H, McConechy MK, McAlpine JN, Nout R, Kommoss S et al (2020) Interpretation of somatic POLE mutations in endometrial carcinoma. J Pathol 250:323\u2013335","journal-title":"J Pathol"},{"key":"3291_CR13","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/01.pas.0000213428.61374.06","volume":"31","author":"I Modica","year":"2007","unstructured":"Modica I, Soslow RA, Black D, Tornos C, Kauff N, Shia J (2007) Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma. Am J Surg Pathol 31:744\u2013751","journal-title":"Am J Surg Pathol"},{"key":"3291_CR14","first-page":"327","volume":"154","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S et al (2021) ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 154:327\u2013353","journal-title":"Int J Gynecol Cancer"},{"key":"3291_CR15","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djh034","volume":"96","author":"A Umar","year":"2004","unstructured":"Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, R\u00fcschoff J et al (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261\u2013268","journal-title":"J Natl Cancer Inst"},{"key":"3291_CR16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","volume":"30","author":"C Luchini","year":"2019","unstructured":"Luchini C, Bibeau F, Ligtenberg MJL, Singh N, Nottegar A, Bosse T et al (2019) ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach. Ann Oncol 30:1232\u20131243","journal-title":"Ann Oncol"},{"key":"3291_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jamaoncol.2018.0104","volume":"4","author":"H Hampel","year":"2018","unstructured":"Hampel H, Pearlman R, Beightol M, Zhao W, Jones D, Frankel WL et al (2018) Assessment of tumour sequencing as a replacement for Lynch syndrome screening and current molecular tests for patients with colorectal cancer. JAMA Oncol 4:806\u2013813","journal-title":"JAMA Oncol"},{"key":"3291_CR18","first-page":"806","volume":"4","author":"E Hissong","year":"2018","unstructured":"Hissong E, Crowe EP, Yantiss RK, Chen YT (2018) Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing. Mod Pathol 4:806\u2013813","journal-title":"Mod Pathol"},{"key":"3291_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00084","author":"S Middha","year":"2018","unstructured":"Middha S, Zhang L, Nafa K, Jayakumaran G, Wong D, Kim HR et al (2018) Reliable pan-cancer microsatellite instability assessment by using targeted next-generation sequencing data. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/PO.17.00084","journal-title":"JCO Precis Oncol"},{"key":"3291_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","volume":"10","author":"J Shia","year":"2008","unstructured":"Shia J (2008) Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. The utility of immunohistochemistry. J Mol Diagnostics 10:293\u2013300","journal-title":"J Mol Diagnostics"},{"key":"3291_CR21","first-page":"02725","volume":"3","author":"H Zhao","year":"2014","unstructured":"Zhao H, Thienpont B, Yesilyurt BT, Moisse M, Reumers J, Coenegrachts L et al (2014) Mismatch repair deficiency endows tumours with a unique mutation signature and sensitivity to DNA double-strand breaks. Elife 3:02725","journal-title":"Elife"},{"key":"3291_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.clcc.2019.05.006","volume":"18","author":"X Li","year":"2019","unstructured":"Li X, Xu J, Li L, Mu X, Wang Y, Li X (2019) Evaluation of a fully automated Idylla test system for microsatellite instability in colorectal cancer. Clin Colorectal Cancer. 18:316\u2013323","journal-title":"Clin Colorectal Cancer."},{"key":"3291_CR23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4132\/jptm.2019.09.25","volume":"53","author":"M Lee","year":"2019","unstructured":"Lee M, Chun SM, Sung CO, Kim SY, Kim TW, Jang SJ et al (2019) Clinical utility of a fully automated microsatellite instability test with minimal hands-on time. J Pathol Transl Med 53:386\u2013392","journal-title":"J Pathol Transl Med"},{"key":"3291_CR24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jmoldx.2019.12.002","volume":"22","author":"K Zwaenepoel","year":"2020","unstructured":"Zwaenepoel K, Holmgaard Duelund J, De Winne K, Maes V, Weyn C, Lambin S et al (2020) Clinical performance of the Idylla MSI test for a rapid assessment of the DNA microsatellite status in human colorectal cancer. J Mol Diagnostics 22:386\u2013395","journal-title":"J Mol Diagnostics"},{"key":"3291_CR25","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/jclinpath-2019-205935","volume":"72","author":"L Samaison","year":"2019","unstructured":"Samaison L, Grall M, Staroz F, Uguen A (2019) Microsatellite instability diagnosis using the fully automated Idylla platform: feasibility study of an in-house rapid molecular testing ancillary to immunohistochemistry in pathology laboratories. J Clin Pathol 72:830\u2013835","journal-title":"J Clin Pathol"},{"issue":"Supplement","key":"3291_CR26","first-page":"8","volume":"29","author":"B De Craene","year":"2018","unstructured":"De Craene B, Van de Velde J, Bellon E, Gazin M, Rondelez E, Vandenbroeck L et al (2018) Detection of microsatellite instability (MSI) with a novel set of 7 Idylla biomarkers on colorectal cancer samples in a multi-center study. Ann Oncol 29(Supplement):8","journal-title":"Ann Oncol"},{"key":"3291_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-021-03082-w","author":"I Ukkola","year":"2021","unstructured":"Ukkola I, Nummela P, Pasanen A, Kero M, Lepist\u00f6 A, Kyt\u00f6l\u00e4 S et al (2021) Detection of microsatellite instability with Idylla\u2122 MSI assay in colorectal and endometrial cancer. Virchows Arch. https:\/\/doi.org\/10.1007\/s00428-021-03082-w","journal-title":"Virchows Arch"},{"key":"3291_CR28","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3390\/cancers13061268","volume":"13","author":"J Siemanowski","year":"2021","unstructured":"Siemanowski J, Sch\u00f6mig-Markiefka B, Buhl T, Haak A, Siebolts U, Dietmaier W, Arens N, Pauly N, Ataseven B, B\u00fcttner R, Merkelbach-Bruse S (2021) Managing difficulties of microsatellite instability testing in endometrial cancer-limitations and advantages of four different PCR-based approaches. Cancers (Basel) 13:1268","journal-title":"Cancers (Basel)"},{"key":"3291_CR29","doi-asserted-by":"publisher","first-page":"16386","DOI":"10.1038\/s41598-020-73421-5","volume":"10","author":"P Gilson","year":"2020","unstructured":"Gilson P, Levy J, Rouyer M, Demange J, Husson M, Bonnet C, Salleron J, Leroux A, Merlin JL, Harl\u00e9 A (2020) Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. Sci Rep 10:16386","journal-title":"Sci Rep"},{"key":"3291_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jclinpath-2020-206581","volume":"74","author":"A P\u00e9criaux","year":"2021","unstructured":"P\u00e9criaux A, Favre L, Calderaro J, Charpy C, Derman J, Pujals A (2021) Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA. J Clin Pathol 74:36\u201342","journal-title":"J Clin Pathol"},{"key":"3291_CR31","doi-asserted-by":"publisher","first-page":"12880","DOI":"10.1038\/s41598-021-91974-x","volume":"11","author":"F Dedeurwaerdere","year":"2021","unstructured":"Dedeurwaerdere F, Claes KB, Van Dorpe J, Rottiers I, Van der Meulen J, Breyne J, Swaerts K, Martens G (2021) Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer. Sci Rep 11:12880","journal-title":"Sci Rep"},{"key":"3291_CR32","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause RJ, Pritchard CC, Shendure J, Salipante SJ (2016) Classification and characterization of microsatellite instability across 18 cancer types. Nat Med 22:1342\u20131350","journal-title":"Nat Med"},{"key":"3291_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jmoldx.2016.07.008","volume":"19","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shi C, Eisenberg R, Vnencak-Jones CL (2017) Differences in microsatellite instability profiles between endometrioid and colorectal cancers: a potential cause for false-negative results? J Mol Diagnostics 19:57\u201364","journal-title":"J Mol Diagnostics"},{"key":"3291_CR34","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/s41379-018-0179-3","volume":"32","author":"X Wu","year":"2019","unstructured":"Wu X, Snir O, Rottmann D, Wong S, Buza N, Hui P (2019) Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation. Mod Pathol 32:650\u2013658","journal-title":"Mod Pathol"},{"key":"3291_CR35","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/S0002-9440(10)61144-3","volume":"160","author":"SA Kuismanen","year":"2002","unstructured":"Kuismanen SA, Moisio AL, Schweizer P, Truninger K, Salovaara R, Arola J et al (2002) Endometrial and colorectal tumours from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability. Am J Pathol 160:1953\u20131958","journal-title":"Am J Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-022-03291-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-022-03291-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T05:09:24Z","timestamp":1650604164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-022-03291-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["3291"],"URL":"https:\/\/doi.org\/10.1007\/s00428-022-03291-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,5]]},"assertion":[{"value":"24 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.The study was approved by local Ethics Committees, according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}